Ultrasound-guided Cryobiopsy of Mediastinal/Hilar Lymph Nodes

NCT06921681 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 136

Last updated 2025-04-10

No results posted yet for this study

Summary

EBUS-guided cryobiopsy of mediastinal and hilar lymph nodes has shown to be a useful diagnostic tool to obtain tissue for histological analysis and further targeted therapies in lung malignancies. Due to the large size and better quality of the tissue samples, a higher diagnostic yield than with transbronchial needle aspiration (TBNA) can be expected, especially in non-solid tumors. In previous studies different biopsy protocols were used. The freezing time of cryoprobe (which defines the sample sizes) ranged from 3 to 7 s and the number of biopsies was between 1 and 4 samples. It is therefore unclear what freezing times and biopsy frequency are required to obtain the best histological information.

Conditions

  • Lung Cancer (NSCLC)

Interventions

DEVICE

Cryobiopsy of lymph nodes group 6 sec

Included patients receive transbronchial access with EBUS needle (19, 21 or 22 gauge needle) Hereafter, three times EBUS-TBNA followed by four EBUS-guided-CBs with a 1.1mm cryoprobe will be performed. Included patients are 1:1 randomized to receive CB with cryoprobe activated for either 3 sec of freezing time (group "3sec") or 6 sec. of freezing time (group "6sec") before the biopsy together with the whole EBUS bronchoscope is extracted. The EBUS-guided CB will be conducted four times in each group. Aiming access to one lymph node if one lymph node cannot be punctured, another lymph node will be chosen. Even if tissue-extraction out of a lymph node via cryoprobe fails once to several times, overall no more than 4 attempts for cryobiopsy will be done

DEVICE

Cryobiopsy lymphnode group 3 sec

Included patients receive transbronchial access with EBUS needle (19, 21 or 22 gauge needle) Hereafter, three times EBUS-TBNA followed by four EBUS-guided-CBs with a 1.1mm cryoprobe will be performed. Included patients are 1:1 randomized to receive CB with cryoprobe activated for either 3 sec of freezing time (group "3sec") or 6 sec. of freezing time (group "6sec") before the biopsy together with the whole EBUS bronchoscope is extracted. The EBUS-guided CB will be conducted four times in each group. Aiming access to one lymph node if one lymph node cannot be punctured, another lymph node will be chosen. Even if tissue-extraction out of a lymph node via cryoprobe fails once to several times, overall no more than 4 attempts for cryobiopsy will be done

Sponsors & Collaborators

  • Aarau Cantonal Hospital (KSA)

    collaborator UNKNOWN
  • Waid City Hospital, Zurich

    collaborator OTHER
  • Kantonsspital Winterthur KSW

    collaborator OTHER
  • Unispital Basel

    collaborator UNKNOWN
  • Spital Uster AG, Uster, Switzerland

    collaborator UNKNOWN
  • Clinique des Grangettes, Chêne-Bougeries

    collaborator UNKNOWN
  • Insel Gruppe AG, University Hospital Bern

    collaborator OTHER
  • Réseau Hospitalier Neuchâtelois

    collaborator OTHER
  • University of Lausanne Hospitals

    collaborator OTHER
  • Cantonal Hospital of St. Gallen

    collaborator OTHER
  • Ospedale Regionale Bellinzona e Valli

    collaborator OTHER
  • HUG - Hôpitaux universitaires de Genève

    collaborator UNKNOWN
  • Kantonsspital Chur, Switzerland

    collaborator UNKNOWN
  • Hôpital du Valais

    collaborator OTHER
  • University of Zurich

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-07
Primary Completion
2029-04-01
Completion
2029-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06921681 on ClinicalTrials.gov